This grand round has already taken place.
Previous research has shown that TB attendants have
indicated that these meetings were beneficial to their practice and sometimes changed
their practice. 5 One of the major problems in practice is how to
manage patients in the recurrent setting after they have failed several
modalities; this topic is addressed continually in the discussion phase of TB
with regards to different diseases. Hence, the reason for many clinical trials
being conducted in the recurrent setting.
The TB conference follows a pre-determined format which
typically lasts about 75 minutes. Each case is briefly presented by a member of
the primary team; radiology and pathology faculty review relevant radiographic
studies and surgical pathology. After discussion and input from Neuro-surgery,
Neuro-oncology and Radiation-oncology a formal treatment decision is
Dates and Times
Start: 11/30/2023 9:00 AM
End: 11/30/2023 10:00 AM
Identify treatment standards for specific CNS tumors including screening, diagnosis, and staging at initial diagnosis and recurrence.
Discuss treatment options for CNS tumors from the viewpoints of Radiation oncologists, Neuro- oncologists, and Neuro-surgeons.
Compare and contrast treatment options for adjuvant therapy.
Describe the role of molecular genetics in treatment and diagnosis of CNS tumors.
Recognize and explain the role of radiographic modalities including perfusion, PET, and functional MRI scans.
Identify open clinical trials and areas of research for CNS tumors.
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Please contact the Grand Round coordinator listed below: